TaiwanJ Pharmaceuticals Co., Ltd. (TPEX:6549)
Taiwan
· Delayed Price · Currency is TWD 7.68
-0.02 (-0.26%)
At close: Mar 10, 2026
TaiwanJ Pharmaceuticals Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Cash & Equivalents | 33.42 | 47.61 | 58.83 | 60.69 | 82.88 | 93.45 | Upgrade
|
| Short-Term Investments | 40 | 40 | - | - | - | - | Upgrade
|
| Cash & Short-Term Investments | 73.42 | 87.61 | 58.83 | 60.69 | 82.88 | 93.45 | Upgrade
|
| Cash Growth | 50.95% | 48.92% | -3.06% | -26.77% | -11.31% | 59.59% | Upgrade
|
| Accounts Receivable | - | - | - | 4.61 | - | - | Upgrade
|
| Other Receivables | 5.25 | 4.98 | 4.85 | 5.68 | 5.26 | 6.26 | Upgrade
|
| Receivables | 5.25 | 4.98 | 4.85 | 10.29 | 5.26 | 6.26 | Upgrade
|
| Prepaid Expenses | 0.36 | 0.27 | 0.18 | 0.17 | 0.25 | 0.33 | Upgrade
|
| Other Current Assets | - | 0.33 | 0.23 | 0.02 | 0 | 0.06 | Upgrade
|
| Total Current Assets | 79.02 | 93.18 | 64.09 | 71.17 | 88.39 | 100.1 | Upgrade
|
| Property, Plant & Equipment | 3.06 | 1.51 | 3.04 | 3.03 | 0.32 | 0.9 | Upgrade
|
| Other Intangible Assets | - | - | 0.36 | 0.94 | 76.8 | 77.38 | Upgrade
|
| Other Long-Term Assets | 6.08 | 6.08 | 6.08 | 4.65 | 4.83 | 4.83 | Upgrade
|
| Total Assets | 88.15 | 100.77 | 73.56 | 79.79 | 170.33 | 183.2 | Upgrade
|
| Accrued Expenses | 2.56 | 4.15 | 4.5 | 4.45 | 5.16 | 5.36 | Upgrade
|
| Current Portion of Leases | 0.77 | 0.47 | 0.7 | 0.69 | 0.33 | 0.56 | Upgrade
|
| Other Current Liabilities | 0.87 | 1.09 | 0.95 | 1.88 | 1.36 | 1.03 | Upgrade
|
| Total Current Liabilities | 4.19 | 5.71 | 6.15 | 7.02 | 6.85 | 6.95 | Upgrade
|
| Long-Term Leases | 1.4 | - | 0.47 | 1.17 | - | 0.33 | Upgrade
|
| Total Liabilities | 5.59 | 5.71 | 6.62 | 8.19 | 6.85 | 7.28 | Upgrade
|
| Common Stock | 801.22 | 801.22 | 751.22 | 751.22 | 751.22 | 751.38 | Upgrade
|
| Additional Paid-In Capital | 2.64 | 2.43 | 1.97 | 0.59 | - | 373.46 | Upgrade
|
| Retained Earnings | -721.3 | -708.59 | -686.25 | -680.2 | -587.74 | -948.81 | Upgrade
|
| Comprehensive Income & Other | - | - | - | - | - | -0.11 | Upgrade
|
| Shareholders' Equity | 82.56 | 95.05 | 66.94 | 71.6 | 163.48 | 175.92 | Upgrade
|
| Total Liabilities & Equity | 88.15 | 100.77 | 73.56 | 79.79 | 170.33 | 183.2 | Upgrade
|
| Total Debt | 2.17 | 0.47 | 1.17 | 1.86 | 0.33 | 0.89 | Upgrade
|
| Net Cash (Debt) | 71.25 | 87.14 | 57.66 | 58.83 | 82.55 | 92.56 | Upgrade
|
| Net Cash Growth | 49.02% | 51.12% | -1.99% | -28.73% | -10.81% | 62.48% | Upgrade
|
| Net Cash Per Share | 0.90 | 1.14 | 0.77 | 0.78 | 1.10 | 1.31 | Upgrade
|
| Filing Date Shares Outstanding | 80.12 | 80.12 | 75.12 | 75.12 | 75.12 | 75.14 | Upgrade
|
| Total Common Shares Outstanding | 80.12 | 80.12 | 75.12 | 75.12 | 75.12 | 75.14 | Upgrade
|
| Working Capital | 74.83 | 87.47 | 57.94 | 64.16 | 81.54 | 93.15 | Upgrade
|
| Book Value Per Share | 1.03 | 1.19 | 0.89 | 0.95 | 2.18 | 2.34 | Upgrade
|
| Tangible Book Value | 82.56 | 95.05 | 66.58 | 70.67 | 86.69 | 98.54 | Upgrade
|
| Tangible Book Value Per Share | 1.03 | 1.19 | 0.89 | 0.94 | 1.15 | 1.31 | Upgrade
|
| Machinery | 4.14 | 3.86 | 3.86 | 2.83 | 2.83 | 2.83 | Upgrade
|
| Leasehold Improvements | 1.64 | 1.64 | 1.64 | 1.23 | 2.56 | 2.56 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.